Thermo Fisher Scientific (TMO)

EBITDA

$2.90B

Quarterly · Period ending: · USD

TMO logo

TMO EBITDA

Latest reported$2.90B
TMO Quarterly EBITDA ($63.10M → $2.90B)
High-resolution chart · PNG

TMO ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Thermo Fisher Scientific EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
2,904,000,000
2,616,000,000
3,216,000,000
2,834,000,000
2,798,000,000
2,628,000,000
3,068,000,000
2,906,000,000
2,977,000,000
2,787,000,000
3,023,000,000
3,011,000,000
2,611,000,000
2,522,000,000
2,894,000,000
2,612,000,000
2,901,000,000
3,535,000,000
2,706,000,000
2,929,000,000
2,829,000,000
3,499,000,000
3,642,000,000
2,971,000,000
1,964,000,000
1,528,000,000
1,756,000,000
1,561,000,000
2,145,000,000
1,561,000,000
1,742,000,000
1,535,000,000
1,547,000,000
1,372,000,000
1,559,500,000
1,154,000,000
1,237,000,000
1,102,800,000
1,257,000,000
974,200,000
1,129,300,000
1,019,700,000
1,110,200,000
996,400,000
1,026,200,000
906,700,000
1,082,000,000
1,007,400,000
1,014,800,000
869,200,000
695,900,000
678,900,000
593,600,000
658,300,000
664,100,000
601,900,000
617,400,000
611,300,000
613,300,000
544,700,000
494,600,000
511,100,000
528,200,000
488,800,000
470,200,000
475,600,000
517,200,000
471,600,000
456,000,000
387,700,000
537,400,000
498,000,000
524,600,000
494,100,000
499,500,000
450,400,000
438,400,000
385,100,000
183,501,000
120,063,000
116,070,000
108,765,000
130,888,000
110,501,000
85,209,000
76,971,000
91,616,000
80,939,000
76,211,000
70,716,000
91,239,000
61,344,000
62,640,000
61,432,000
74,218,000
65,605,000
44,102,000
59,653,000
64,559,000
63,750,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.